Schedule 13D ownership disclosure
Edge Therapeutics, Inc.
Security class unavailable · CUSIP: 279870109
Event date: 2015-10-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001596770-15-000052
- Form type
- SC 13D
- Filer
- PDS Biotechnology Corp
- CIK
- CIK 1472091
- Filed
- Oct 16, 2015
- Reporting period
- Oct 06, 2015
- Description
- Schedule 13D beneficial ownership